Pomerantz LLP Appointed Lead Counsel in Sarepta Therapeutics Securities Litigation

On December 17, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.